| Category: |
Antibody |
| Concentration: |
pH7, with 0, 02% sodium azide, 3, 5 mg/ml in 1X TBS, 5% BSA (US sourced) and 0 |
| Form: |
Antigen affinity purified |
| Conjugation: |
Unconjugated |
| Clone: |
Polyclonal antibody |
| Recognised antigen: |
OSMR |
| Host animal: |
Goat (Capra aegagrus hircus) |
| Clonality: |
Polyclonal (goat origin) |
| Species reactivity: |
Due to limited knowledge and inability to test the antibody against all known species, we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens) |
| Tested applications: |
ELISA (peptide), WB |
| Recommended dilutions: |
1-0, 3ug/ml, ELISA (peptide) LOD: 1:128000, Western blot: 0 |
| Notes: |
Optimal dilution of the OSMR antibody should be determined by the researcher |
| Intented use: |
This OSMR antibodyis to be used only for research purposes and not for diagnostics |
| Gene ID #: |
9180 |
| Purity: |
Antigen affinity |
| Description: |
Additional name(s) for this target protein: Oncostatin M receptor |
| Immunogen: |
The amino acid sequence used as immunogen is from the extracellular portion of the protein, Amino acids QIHGEQLDPHVT were used as the immunogen for this OSMR antibody |
| Storage: |
Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, Aliquot and store the OSMR antibody at -20 deg |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24° |
| Gene target: |
OSMR |
| Short name: |
OSMR Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
oncostatin M receptor (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
BT, OSMR and IDBG-17615 and ENSG00000145623 and 9180, OSMRB and PLCA1, Osmr and IDBG-128241 and ENSMUSG00000022146 and 18414, growth factor binding, multiple, this GO :0002675 and positive regulation of acute inflammatory response and biological process this GO :0004924 and oncostatin-M receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005900 and oncostatin-M receptor complex and cellular component this GO :0007166 and cell surface receptor signaling pathway and biological process this GO :0008283 and cell proliferation and biological process this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0019838 and growth factor binding and molecular function this GO :0034097 and response to cytokine and biological process this GO :0038165 and oncostatin-M-mediated signaling pathway and biological process, this GO :0004924 : oncostatin-M receptor activity, this GO :0004924 : oncostatin-M receptor activity and also this GO :0005515 : protein binding and also this GO :0019838 : growth factor binding, this GO :0005515 : protein binding, this GO :0019838 : growth factor binding, 103407 and IDBG-629972 and ENSBTAG00000033107 and 514720, oncostatin M receptor |
| Identity: |
8507 |
| Gene: |
OSMR |
More about : OSMR |
| Long gene name: |
oncostatin M receptor |
| Synonyms: |
OSMRB |
| Locus: |
5p13, 1 |
| Discovery year: |
1999-02-17 |
| GenBank acession: |
U60805 |
| Entrez gene record: |
9180 |
| Pubmed identfication: |
8999038 |
| RefSeq identity: |
NM_003999 |
| Classification: |
Fibronectin type III domain containing |
| Havana BLAST/BLAT: |
OTTHUMG00000090811 |